3 Things
Shortage of TB drugs, 300 days of farmers' protests, and the new RBI Chief
Dec 10, 2024
Anonna Dutt, an investigative journalist at The Indian Express specializing in healthcare, discusses a critical shortage of tuberculosis medications in India, spotlighting how this affects efforts to combat the disease. Raakhi Jagga, also from The Indian Express, provides an update on the farmers' protests, which have now lasted over 300 days, emphasizing their calls for Minimum Support Price reforms. The conversation also touches on the recent appointment of a new RBI Governor, highlighting the challenges that lie ahead in balancing growth and inflation.
25:11
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- India's TB drug shortage is critically hindering disease elimination efforts due to procurement issues and supplier blacklisting.
- Ongoing farmers' protests highlight the demand for a legal Minimum Support Price, as dissatisfaction rises from unfulfilled government promises.
Deep dives
Shortage of TB Drugs in India
India is facing a significant shortage of essential tuberculosis (TB) drugs, which is hindering efforts to eliminate the disease by 2025. Investigations revealed that states have been unable to procure necessary medicines due to delays from the central government and difficulties in sourcing locally. Notably, at least three suppliers of TB medicines were blacklisted for failing to deliver on time or providing incorrect pricing, exacerbating the drug shortage. With India accounting for a significant portion of global TB cases, these procurement issues are critical to address to prevent worsening health outcomes for TB patients.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
